#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Scott Wilhoit Email
EVP Global Commercial . Savara
Austin, TX
Locations************@savarapharma.com
Primary EmailHow to contact Scott Wilhoit
Join and see Scott's contact info for free!Current Roles
Employees:
42Revenue:
$6.8MAbout
Savara Inc. is an orphan lung disease company. Savara's pipeline comprises: Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for PAP, and in Phase 2a development for NTM lung infection; and AeroVanc, a Phase 3 stage inhaled vancomycin for treatment of MRSA infection in cystic fibrosis. Savara's strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field. Savara's management team has significant experience in orphan drug development and pulmonary medicine, in identifying unmet needs, developing and acquiring new product candidates, and effectively advancing them to approvals and commercialization. More information can be found at www.savarapharma.com. (Twitter: @SavaraPharma)Savara Address
6836 Bee Cave RoadAustin, TX
United States